eMagin (EMAN) Stock Rating Lowered by Zacks Investment Research

eMagin (NYSEAMERICAN:EMAN) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Wednesday, Zacks.com reports.

According to Zacks, “eMagin Corporation is a leading developer of virtual imaging technology, eMagin combines integrated circuits, microdisplays, and optics to create a virtual image equivalent to the real image of a computer monitor or large screen TV. These miniature, high-performance, virtual imaging modules provide access to information-rich text, data, and video which can facilitate the opening of new mass markets for wearable PCs, wireless Internet appliances and mobile phones, portable DVD-viewers, digital cameras, and other emerging applications. “

Separately, HC Wainwright set a $2.00 price target on eMagin and gave the company a “buy” rating in a research note on Monday, April 22nd.

NYSEAMERICAN EMAN opened at $0.55 on Wednesday. eMagin has a fifty-two week low of $0.48 and a fifty-two week high of $1.95.

eMagin (NYSEAMERICAN:EMAN) last announced its quarterly earnings results on Thursday, May 9th. The semiconductor company reported ($0.03) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.03). The business had revenue of $6.11 million during the quarter, compared to analyst estimates of $6.30 million. During the same period last year, the company earned ($0.05) EPS.

About eMagin

eMagin Corporation designs, develops, manufactures, and markets organic light emitting diode (OLED) displays on-silicon micro displays; virtual imaging products that utilize OLED micro displays; and related products. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS and OLED-XL; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL/XLS.

Featured Article: Investing in Blue-Chip Stocks

Get a free copy of the Zacks research report on eMagin (EMAN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.